AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
AGE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -0.41%181.760.7%$1405.68m
MRKMerck & Co., Inc. -0.21%93.080.7%$1238.86m
PFEPfizer Inc. -0.17%51.610.9%$1232.04m
BMYBristol-Myers Squibb Co. -0.17%78.861.0%$1135.54m
LLYEli Lilly & Co. -0.10%325.351.1%$1134.85m
ABBVAbbVie, Inc. 0.22%152.881.9%$1021.46m
AZNAstraZeneca Plc -0.72%66.421.0%$448.85m
SGENSeagen Inc. -1.61%176.455.7%$320.77m
GSKGSK Plc -0.46%43.490.2%$296.07m
TPTXTurning Point Therapeutics, Inc. 0.00%75.170.0%$291.93m
MRTXMirati Therapeutics, Inc. 2.70%70.001.6%$204.79m
SIGASIGA Technologies, Inc. -11.81%11.500.0%$193.74m
HZNPHorizon Therapeutics Plc 0.00%85.135.4%$182.59m
NVSNovartis AG -0.04%84.790.2%$167.69m
NVONovo Nordisk A/S 0.58%112.820.1%$148.21m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.